Surfactant protein-D (SP-D) gene polymorphisms and serum level as predictors of susceptibility and prognosis of acute kidney injury in the Chinese population

Table 6 Baseline serum SP-D levels and patients’ outcome, AKI stage and RRT of AKI patients

AKI patients	Outcome		AKI stage			RRT
AKI patients	Dead	Alive	Stage 1	Stage 2	Stage 3	With	Without
Median(25^th – 75^th IQR) serum SP-D(ng/ml)	149.6 (143.8–159.2)	139.5* (124.1–154.6)	124.3 (120.4–123.4)	137.7* (131.3–144.0)	156.1^##(148.9–165.1)	142.7 (139.5–159.8)	140.3* (121.7–155.8)
P value	0.026		1	0.02	0.001	0.012

For the serum SP-D levels and different outcome analysis
*Compared with AKI patients who died, significant difference was observed. P less than 0.05
For the serum SP-D levels and different AKI stage analysis
*Compared with AKI stage 1,significant difference was observed. P less than 0.05
^##Compared with AKI stage 3,significant difference was observed. P less than 0.01
For the serum SP-D levels and RRT need
*Compared with AKI patients with RRT, significant difference was observed. P less than 0.05

ISSN: 1471-2369